The Emerging Role and Value of HRD Testing in Ovarian Cancer - EMG

Continue

The Emerging Role and Value of HRD Testing in Ovarian Cancer

Oncology
General Healthcare
Bonus Episode

The Emerging Role and Value of HRD Testing in Ovarian Cancer

This episode, sponsored by an educational grant from AstraZeneca, is on the topic of ovarian cancer. Hear from two experts in the field, Professor Frederik Marmé and Professor Christina Fotopoulou, as they discuss the impact of late diagnosis and delayed treatment on patient outcomes, risk reduction strategies, and HRD testing.

Spotify | Apple

Download MP3 (mp 44:40 mins)

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given